glp-1 drug makers Drugmakers are only months into introducing pills and navigating huge changes in 9 Companies Developing Next-Generation GLP-1

For a deeper breakdown of what to expect month by month, read our guide on how long glutathione takes to lighten skin

Conditions include alcoholic liver disease, viral hepatitis, cirrhosis, and primary or metastatic liver cancer Renal dysfunction : Impaired kidney function reduces B12 elimination, causing accumulation even with normal intake Haematological conditions : Myeloproliferative neoplasms, chronic myeloid leukaemia, polycythaemia vera, and hypereosinophilic syndrome increase transcobalamin production, elevating total serum B12 Laboratory interference : Macro-B12 (immunoglobulin-bound B12) and assay interference can cause spuriously elevated results without true excess In clinical practice, unexplained hypercobalaminaemia should prompt investigation for underlying disease, particularly in patients without obvious supplementation history

Acetyl-L-carnitine: Overview

Nausea occurred at significantly elevated rates across all dose levels compared to placebo